Cannoperations, a wholly owned subsidiary of Cann Group Ltd., has become the first company to be granted a license to produce and cultivate medical cannabis for manufacture in Australia.

The Office of Drug Control, the country’s medical cannabis regulator, made the announcement on March 8, just weeks after the office granted Cann Group a license to grow cannabis for medical research purposes.

While licenses have been issued to state governments, these are the first granted to a commercial entity. Cann Group has not announced whether it has also applied for a manufacturing license or whether the company will provide cannabis to other manufacturers.

In October 2015 the then premier of NSW Mike Baird published a lengthy note on his Facebook page about an encounter he’d had with a young boy named Tyler Oldenburg.

Tyler has up to 40 seizures a day and his mother, Nicole, thinks medicinal cannabis will help. Baird said he was proud that NSW was “leading the nation” in researching the controversial drug.

“It’s my deepest hope that, as a result of these trials, Tyler and his family will soon be able to face a much brighter future,” he wrote.

Stemcell United Ltd (ASX:SCU) ("SCU" "the Company") is pleased to announce the appointment of Medicinal Cannabis expert Mr. Nevil Schoenmakers as a Strategic Advisor to the Board to assist the Company assess opportunities in the medicinal cannabis sector.

- Leading Medicinal Cannabis industry expert Mr. Nevil Schoenmakers appointed as a Strategic Advisor

- Stemcell United Ltd to pursue investment opportunities Medicinal Cannabis to complement its existing and continuing Traditional Medicine operations

- Global Medicinal Cannabis market projected to reach USD $55.8 billion by 2025

THC is expecting net profit of over $1 million in 2017.

The Hydroponics Company (ASX:THC) aims to list on the ASX through an initial public offering (IPO) of up to 40 million shares priced at $0.20 to raise up to $8 million.

Funds will be used to expand THC’s market share as a key manufacturer and distributor of hydroponics equipment, materials and related services.

The company is targeting to list on the ASX on the 20th of April, 2017 under the ticker code THC.

Queensland could have looked at a compassionate scheme to not prosecute people using whole plant medicinal cannabis, the state's One Nation MP says.

Member for Buderim Steve Dickson said in that New South Wales police were given guidelines not to prosecute terminally ill people found with small amounts of cannabis.

A parliamentary committee is considering One Nation MP Steve Dickson's medicinal cannabis bill. Photo: Rohan Thomson

"We did not use that component in the Queensland legislation where governments will not prosecute people that are using whole plant medicinal cannabis," Mr Dickson said.

Australia's first medical marijuana farm received its growers' licence Wednesday, opening up domestic production of the drug for people seeking relief from serious illnesses.

The Cann Group, who last month received a cannabis research license, was awarded the cultivation permit after a "rigorous on-site security assessment".

"This major development will lead to improved access to domestically produced medicinal cannabis products for Australian patients," said Health Minister Greg Hunt.

While the U.S. continues to squabble state-by-state over medical and adult use legalization, over the past year cannabis has quietly grown into a truly international industry.

It could have once been a stretch of the imagination of Queensland Bauxite shareholders to think that they could be treated to crop updates from the Northern NSW hippie paradise of Nimbin.

But the veteran gold fossicker and Queensland Bauxite executive chairman Pnina "Diamond Rose" Feldman has taken to a business founded by a former Nimbin café owner.

"Excellent market positioning for the anticipated rapid economic growth in the medical cannabis sector and hemp seed food industry in Australia and globally," trumpeted an ASX announcement by Diamond Rose last week, where she disclosed Queensland Bauxite would buy 55 per cent of the Nimbin-domiciled Medical Cannabis Limited (MCL).

Twenty-nine critically ill children will be granted early access to a medical cannabis treatment grown by the Victorian Government, it has been announced.

The children, who all suffer from epilepsy, will be granted access to medical cannabis imported by the State Government from Canada.

"To enable this compassionate access, a limited amount of cannabidool oral solution manufactured by Canadian company Tilray... was purchased by the government and arrived in Melbourne late last week," the government said in a statement.

Australian patients struggling to access medical cannabis are welcoming the Australian government’s announcement last week to allow importers to source cannabis products from international suppliers. The change is expected to ensure that patients currently waiting for medicine obtain it within eight weeks. But uncertainty still surrounds the changes, and experts are now calling for a more comprehensive approach to meeting Australian demand for medical cannabis.